524636 — Oxygenta Pharmaceutical Balance Sheet
0.000.00%
Last trade - 00:00- IN₹1.10bn
- IN₹1.67bn
- IN₹396.42m
Annual balance sheet for Oxygenta Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.18 | 4.45 | 1.56 | 1.06 | 1.01 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9.02 | 16.5 | 15.8 | 102 | 73.6 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 67.7 | 159 | 95.6 | 250 | 241 |
| Net Property, Plant And Equipment | 114 | 170 | 203 | 279 | 294 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 186 | 339 | 312 | 543 | 632 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 170 | 188 | 80.7 | 298 | 337 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 596 | 719 | 658 | 1,005 | 833 |
| Common Stock | |||||
| Other Equity | |||||
| Total Equity | -409 | -380 | -346 | -462 | -201 |
| Total Liabilities & Shareholders' Equity | 186 | 339 | 312 | 543 | 632 |
| Total Common Shares Outstanding |